<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04262817</url>
  </required_header>
  <id_info>
    <org_study_id>2000025687</org_study_id>
    <nct_id>NCT04262817</nct_id>
  </id_info>
  <brief_title>The Interaction of Flavor With Nicotine Form in Adult Smokers</brief_title>
  <official_title>The Interaction of Flavor With Nicotine Form in Adult Smokers</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Yale University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Yale University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study seeks to elucidate the impact of e-cigarette flavor on subjective effects and
      nicotine exposure from e-cigarettes containing different forms of nicotine.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">June 2020</start_date>
  <completion_date type="Anticipated">May 2021</completion_date>
  <primary_completion_date type="Anticipated">May 2021</primary_completion_date>
  <phase>Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>Double (Participant, Care Provider)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Changes in liking of e-cigarette</measure>
    <time_frame>up to 3 weeks</time_frame>
    <description>Drug effect questionnaire; 0(&quot;not at all&quot;) to 100(&quot;extremely&quot;) mm scale</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Changes in liking of e-cigarette</measure>
    <time_frame>up to 3 weeks</time_frame>
    <description>Labeled Hedonic Scale ; âˆ’100 (most disliked) to 100 (most liked)</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Nicotine Dependence</condition>
  <arm_group>
    <arm_group_label>E-cigarette flavor</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>In this arm, participants will receive two experimental e-cigarette flavors</description>
  </arm_group>
  <arm_group>
    <arm_group_label>E-cigarette nicotine form</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>In this arm, participants will receive two forms of nicotine in an e-cigarette</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Nicotine form</intervention_name>
    <description>participants will receive 36mg/ml nicotine salt and freebase nicotine</description>
    <arm_group_label>E-cigarette flavor</arm_group_label>
    <arm_group_label>E-cigarette nicotine form</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>E-cigarette experimental flavor</intervention_name>
    <description>Participants will receive menthol and tobacco flavored e-cigarettes</description>
    <arm_group_label>E-cigarette flavor</arm_group_label>
    <arm_group_label>E-cigarette nicotine form</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  At least 21 years old, able to read and write, use of combustible

        Exclusion Criteria:

        -
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Asti Jackson, PhD</last_name>
    <phone>2039747598</phone>
    <email>asti.jackson@yale.edu</email>
  </overall_contact>
  <verification_date>May 2020</verification_date>
  <study_first_submitted>February 4, 2020</study_first_submitted>
  <study_first_submitted_qc>February 6, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">February 10, 2020</study_first_posted>
  <last_update_submitted>May 28, 2020</last_update_submitted>
  <last_update_submitted_qc>May 28, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">May 29, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Yale University</investigator_affiliation>
    <investigator_full_name>Asti Jackson</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Tobacco Use Disorder</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Nicotine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

